161 related articles for article (PubMed ID: 29185022)
21. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial.
Nicol GE; Yingling MD; Flavin KS; Schweiger JA; Patterson BW; Schechtman KB; Newcomer JW
JAMA Psychiatry; 2018 Aug; 75(8):788-796. PubMed ID: 29898210
[TBL] [Abstract][Full Text] [Related]
23. QT and QTc in Male Patients with Psychotic Disorders Treated with Atypical Neuroleptics.
Miniati M; Simoncini M; Vanelli F; Franceschini C; Massimetti G; Carmassi C; Dell'Osso L
ScientificWorldJournal; 2017; 2017():1951628. PubMed ID: 28785719
[TBL] [Abstract][Full Text] [Related]
24. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
25. Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Hum Psychopharmacol; 2013 Jan; 28(1):94-6. PubMed ID: 23161621
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: a randomised, double-blind, crossover study (eXtRa).
Riedel M; Schmitz M; Østergaard PK; Ferrannini L; Franco MA; Alfano V; Vansvik ED
Schizophr Res; 2015 Mar; 162(1-3):162-8. PubMed ID: 25592805
[TBL] [Abstract][Full Text] [Related]
27. Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine.
Korell J; Green B; Rae A; Remmerie B; Vermeulen A
Eur J Clin Pharmacol; 2018 May; 74(5):593-599. PubMed ID: 29392351
[TBL] [Abstract][Full Text] [Related]
28. Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison.
Pozzi M; Pisano S; Bertella S; Capuano A; Rizzo R; Antoniazzi S; Auricchio F; Carnovale C; Cattaneo D; Ferrajolo C; Gentili M; Guastella G; Mani E; Rafaniello C; Riccio MP; Scuderi MG; Sperandeo S; Sportiello L; Villa L; Radice S; Clementi E; Rossi F; Pascotto A; Bernardini R; Molteni M; Bravaccio C
J Clin Psychiatry; 2016 Dec; 77(12):e1601-e1609. PubMed ID: 27780333
[TBL] [Abstract][Full Text] [Related]
29. Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: results of a 6-week, randomized, flexible-dose, open-label comparison.
Crespo-Facorro B; Pérez-Iglesias R; Mata I; Ortiz-Garcia de la Foz V; Martínez-Garcia O; Valdizan EM; Vazquez-Barquero JL
J Clin Psychopharmacol; 2013 Apr; 33(2):215-20. PubMed ID: 23422371
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
[TBL] [Abstract][Full Text] [Related]
31. Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study.
Correll CU; Kohegyi E; Zhao C; Baker RA; McQuade R; Salzman PM; Sanchez R; Nyilas M; Carson W
J Am Acad Child Adolesc Psychiatry; 2017 Sep; 56(9):784-792. PubMed ID: 28838583
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Hum Psychopharmacol; 2013 May; 28(3):215-9. PubMed ID: 23553637
[TBL] [Abstract][Full Text] [Related]
33. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
De Deyn PP; Eriksson H; Svensson H;
Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
[TBL] [Abstract][Full Text] [Related]
35. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
Swainston Harrison T; Perry CM
Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
[TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
[TBL] [Abstract][Full Text] [Related]
37. Impact of Quetiapine Therapy on QTc Prolongation in Critically Ill Patients.
Lee S; Morris A; Kim S; Li F; Baumgartner L
Ann Pharmacother; 2019 Jul; 53(7):705-710. PubMed ID: 30704263
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
Pan PY; Lee MS; Yeh CB
BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
[TBL] [Abstract][Full Text] [Related]
39. Relationship Between Daily Dose, Serum Concentration, and Clinical Response to Quetiapine in Children and Adolescents with Psychotic and Mood Disorders.
Albantakis L; Egberts K; Burger R; Kulpok C; Mehler-Wex C; Taurines R; Unterecker S; Wewetzer C; Romanos M; Gerlach M
Pharmacopsychiatry; 2017 Nov; 50(6):248-255. PubMed ID: 28561203
[No Abstract] [Full Text] [Related]
40. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
